Lista de obras -

A Practical Guide to Immunoassay Method Validation

artículo científico publicado en 2015

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

scientific article published on 05 April 2011

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

artículo científico publicado en 2017

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

artículo científico publicado en 2014

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.

artículo científico publicado en 2017

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies

artículo científico publicado en 2018

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis

artículo científico publicado en 2016

Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.

artículo científico publicado en 2017

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

artículo científico

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

artículo científico publicado en 2017

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid

artículo científico publicado en 2014

Immunological profile of silent brain infarction and lacunar stroke

artículo científico publicado en 2013

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease

artículo científico publicado en 2017

Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.

artículo científico publicado en 2016

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

artículo científico publicado en 2019

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

artículo científico publicado en 2016

Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.

artículo científico publicado en 2012

Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.

artículo científico publicado en 2015

Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies

artículo científico publicado en 2020

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

artículo científico publicado en 2011

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

artículo científico publicado en 2015

Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis

artículo científico publicado en 2016

Lista de obras de

A Practical Guide to Immunoassay Method Validation

Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias

Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis.

Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease

Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients.

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis

Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.

Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia

Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid

Immunological profile of silent brain infarction and lacunar stroke

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease

Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine

Performance of aβ1-40, aβ1-42, total tau, and phosphorylated tau as predictors of dementia in a cohort of patients with mild cognitive impairment.

Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies.

Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study

Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis